Silk Fibroin Sponges with Cell Growth-promoting Activity Induced by Genetically Fused Basic Fibroblast Growth Factor
Overview
Affiliations
Transgenic silkworm technology has enabled the biological properties of silk fibroin protein to be altered by fusion to recombinant bioactive proteins. However, few studies have reported the fabrication of genetically modified fibroin proteins into three-dimensional spongy structures to serve as scaffolds for tissue engineering. We generated a transgenic silkworm strain that produces fibroin fused to basic fibroblast growth factor (bFGF) and processed the fibroin into a spongy structure using a simple freeze/thaw method. NIH3T3 mouse embryonic fibroblasts grown on bFGF-fused fibroin sponges proliferated and spread out well, showing half the population doubling time of cells cultured on wild-type fibroin sponges. Furthermore, the number of primary rabbit articular chondrocytes growing on bFGF-fused fibroin sponges was around five-times higher than that of the wild-type control at 3-days post cell-seeding. As the physical properties of wild-type and bFGF-fused fibroin sponges were almost identical, it is suggested that bFGF fused to fibroin retained its biological activity, even after the bFGF-fused fibroin was fabricated into the spongy structure. The bFGF-fused fibroin sponge has the potential for widespread application in the field of tissue engineering, and the method of fabricating this structure could be applicable to other recombinant bioactive fibroin proteins.
Yamada M, Nakajima A, Sakurai K, Tamada Y, Nakagawa K J Funct Biomater. 2024; 15(8).
PMID: 39194668 PMC: 11355749. DOI: 10.3390/jfb15080230.
Kim Y, Bae Y, Jang M, Um I Biomolecules. 2023; 13(8).
PMID: 37627251 PMC: 10452508. DOI: 10.3390/biom13081186.
Sericultural By-Products: The Potential for Alternative Therapy in Cancer Drug Design.
Baci G, Baciu E, Cucu A, Musca A, Giurgiu A, Moise A Molecules. 2023; 28(2).
PMID: 36677907 PMC: 9861160. DOI: 10.3390/molecules28020850.
Fractionation of Regenerated Silk Fibroin and Characterization of the Fractions.
Aoki M, Masuda Y, Ishikawa K, Tamada Y Molecules. 2021; 26(20).
PMID: 34684897 PMC: 8540890. DOI: 10.3390/molecules26206317.
Lin M, Lu M, Chan Y, Huang Y, Chang H Pharmaceutics. 2021; 13(9).
PMID: 34575535 PMC: 8468198. DOI: 10.3390/pharmaceutics13091459.